dc.contributor.author | Kilic, Leyla | |
dc.contributor.author | Ekenel, Meltem | |
dc.contributor.author | Ciftci, Rumeysa | |
dc.contributor.author | Keskin, Sezai | |
dc.contributor.author | Tas, Faruk | |
dc.contributor.author | Vatansever, Sezai | |
dc.contributor.author | Yildiz, Ibrahim | |
dc.contributor.author | Karabulut, Senem | |
dc.contributor.author | Sen, Fatma | |
dc.date.accessioned | 2021-03-06T09:35:24Z | |
dc.date.available | 2021-03-06T09:35:24Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Keskin S., Tas F., Ekenel M., Kilic L., Sen F., Yildiz I., Karabulut S., Ciftci R., Vatansever S., "Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.", Tumori, cilt.99, ss.463-8, 2013 | |
dc.identifier.issn | 0300-8916 | |
dc.identifier.other | av_e64139a0-2457-4309-b3f6-2544974a6fc5 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/151474 | |
dc.identifier.uri | https://doi.org/10.1700/1361.15095 | |
dc.description.abstract | Aims and background. To investigate the efficacy and tolerability of biweekly scheduled triplet chemotherapy consisting of gemcitabine, cisplatin and vinorelbine for chemotherapy-naive advanced non-small cell lung cancer. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer. | |
dc.type | Makale | |
dc.relation.journal | Tumori | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 99 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 463 | |
dc.identifier.endpage | 8 | |
dc.contributor.firstauthorID | 30096 | |